Hereditary spinocerebellar ataxia (ICD-11 8A03.1Z) is the focus of this evidence-based clinical protocol. Determining the appropriate management approach for this condition is a key priority in practice.
There are currently no approved treatments to improve the underlying ataxia in the majority of the progressive ataxias, although research advances may result in medications in the future. The full protocol sets out the structured management approach for this diagnosis.
There are currently no approved treatments to improve the underlying ataxia in the majority of the progressive ataxias, although research advances may result in medications in the future.
View source ↗